CSR1 induces cell death through inactivation of CPSF3

CSR1 (cellular stress response 1), a newly characterized tumor-suppressor gene, undergoes hypermethylation in over 30% of prostate cancers. Re-expression of CSR1 inhibits cell growth and induces cell death, but the mechanism by which CSR1 suppresses tumor growth is not clear. In this study, we scree...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 28; no. 1; pp. 41 - 51
Main Authors Zhu, Z-H, Yu, Y P, Shi, Y-K, Nelson, J B, Luo, J-H
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 08.01.2009
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract CSR1 (cellular stress response 1), a newly characterized tumor-suppressor gene, undergoes hypermethylation in over 30% of prostate cancers. Re-expression of CSR1 inhibits cell growth and induces cell death, but the mechanism by which CSR1 suppresses tumor growth is not clear. In this study, we screened a prostate cDNA library using a yeast two-hybrid system and found that the cleavage and polyadenylation-specific factor 3 (CPSF3), an essential component for converting heteronuclear RNA to mRNA, binds with high affinity to the CSR1 C terminus. Further analyses determined that the binding motifs for CPSF3 are located between amino acids 440 and 543. The interaction between CSR1 and CPSF3 induced CPSF3 translocation from the nucleus to the cytoplasm, resulting in inhibition of polyadenylation both in vitro and in vivo . Downregulation of CPSF3 using small interfering RNA induced cell death in a manner similar to CSR1 expression. A CSR1 mutant unable to bind to CPSF3 did not alter CPSF3 subcellular distribution, did not inhibit its polyadenylation activity and did not induce cell death. In summary, CSR1 appears to induce cell death through a novel mechanism by hijacking a critical RNA processing enzyme.
AbstractList CSR1 (cellular stress response 1), a newly characterized tumor-suppressor gene, undergoes hypermethylation in over 30% of prostate cancers. Re-expression of CSR1 inhibits cell growth and induces cell death, but the mechanism by which CSR1 suppresses tumor growth is not clear. In this study, we screened a prostate cDNA library using a yeast two-hybrid system and found that the cleavage and polyadenylation-specific factor 3 (CPSF3), an essential component for converting heteronuclear RNA to mRNA, binds with high affinity to the CSR1 C terminus. Further analyses determined that the binding motifs for CPSF3 are located between amino acids 440 and 543. The interaction between CSR1 and CPSF3 induced CPSF3 translocation from the nucleus to the cytoplasm, resulting in inhibition of polyadenylation both in vitro and in vivo. Downregulation of CPSF3 using small interfering RNA induced cell death in a manner similar to CSR1 expression. A CSR1 mutant unable to bind to CPSF3 did not alter CPSF3 subcellular distribution, did not inhibit its polyadenylation activity and did not induce cell death. In summary, CSR1 appears to induce cell death through a novel mechanism by hijacking a critical RNA processing enzyme.
CSR1 (cellular stress response 1), a newly characterized tumor-suppressor gene, undergoes hypermethylation in over 30% of prostate cancers. Re-expression of CSR1 inhibits cell growth and induces cell death, but the mechanism by which CSR1 suppresses tumor growth is not clear. In this study, we screened a prostate cDNA library using a yeast two-hybrid system and found that the cleavage and polyadenylation-specific factor 3 (CPSF3), an essential component for converting heteronuclear RNA to mRNA, binds with high affinity to the CSR1 C terminus. Further analyses determined that the binding motifs for CPSF3 are located between amino acids 440 and 543. The interaction between CSR1 and CPSF3 induced CPSF3 translocation from the nucleus to the cytoplasm, resulting in inhibition of polyadenylation both in vitro and in vivo. Downregulation of CPSF3 using small interfering RNA induced cell death in a manner similar to CSR1 expression. A CSR1 mutant unable to bind to CPSF3 did not alter CPSF3 subcellular distribution, did not inhibit its polyadenylation activity and did not induce cell death. In summary, CSR1 appears to induce cell death through a novel mechanism by hijacking a critical RNA processing enzyme. doi:10.1038/onc.2008.359; published online 22 September 2008 Keywords: CSR1; CPSF3; cell death; RNA polyadenylation
CSR1 (cellular stress response 1), a newly characterized tumor-suppressor gene, undergoes hypermethylation in over 30% of prostate cancers. Re-expression of CSR1 inhibits cell growth and induces cell death, but the mechanism by which CSR1 suppresses tumor growth is not clear. In this study, we screened a prostate cDNA library using a yeast two-hybrid system and found that the cleavage and polyadenylation-specific factor 3 (CPSF3), an essential component for converting heteronuclear RNA to mRNA, binds with high affinity to the CSR1 C terminus. Further analyses determined that the binding motifs for CPSF3 are located between amino acids 440 and 543. The interaction between CSR1 and CPSF3 induced CPSF3 translocation from the nucleus to the cytoplasm, resulting in inhibition of polyadenylation both in vitro and in vivo. Downregulation of CPSF3 using small interfering RNA induced cell death in a manner similar to CSR1 expression. A CSR1 mutant unable to bind to CPSF3 did not alter CPSF3 subcellular distribution, did not inhibit its polyadenylation activity and did not induce cell death. In summary, CSR1 appears to induce cell death through a novel mechanism by hijacking a critical RNA processing enzyme. [PUBLICATION ABSTRACT]
CSR1 (cellular stress response 1), a newly characterized tumor-suppressor gene, undergoes hypermethylation in over 30% of prostate cancers. Re-expression of CSR1 inhibits cell growth and induces cell death, but the mechanism by which CSR1 suppresses tumor growth is not clear. In this study, we screened a prostate cDNA library using a yeast two-hybrid system and found that the cleavage and polyadenylation-specific factor 3 (CPSF3), an essential component for converting heteronuclear RNA to mRNA, binds with high affinity to the CSR1 C terminus. Further analyses determined that the binding motifs for CPSF3 are located between amino acids 440 and 543. The interaction between CSR1 and CPSF3 induced CPSF3 translocation from the nucleus to the cytoplasm, resulting in inhibition of polyadenylation both in vitro and in vivo . Downregulation of CPSF3 using small interfering RNA induced cell death in a manner similar to CSR1 expression. A CSR1 mutant unable to bind to CPSF3 did not alter CPSF3 subcellular distribution, did not inhibit its polyadenylation activity and did not induce cell death. In summary, CSR1 appears to induce cell death through a novel mechanism by hijacking a critical RNA processing enzyme.
Audience Academic
Author Nelson, J B
Luo, J-H
Yu, Y P
Shi, Y-K
Zhu, Z-H
AuthorAffiliation 1 Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
2 Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
AuthorAffiliation_xml – name: 2 Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
– name: 1 Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Author_xml – sequence: 1
  givenname: Z-H
  surname: Zhu
  fullname: Zhu, Z-H
  organization: Department of Pathology, University of Pittsburgh School of Medicine
– sequence: 2
  givenname: Y P
  surname: Yu
  fullname: Yu, Y P
  organization: Department of Pathology, University of Pittsburgh School of Medicine
– sequence: 3
  givenname: Y-K
  surname: Shi
  fullname: Shi, Y-K
  organization: Department of Pathology, University of Pittsburgh School of Medicine
– sequence: 4
  givenname: J B
  surname: Nelson
  fullname: Nelson, J B
  organization: Department of Urology, University of Pittsburgh School of Medicine
– sequence: 5
  givenname: J-H
  surname: Luo
  fullname: Luo, J-H
  email: luoj@msx.upmc.edu
  organization: Department of Pathology, University of Pittsburgh School of Medicine
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21234814$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18806823$$D View this record in MEDLINE/PubMed
BookMark eNqF0s1rFDEUAPAgFbut3jzLoNSTsyYvH5NchLK0KhQUq-eQzWR2U2aTNpkp-N-bYZauFUXmEGbeL2-S994JOgoxOIReErwkmMr3MdglYCyXlKsnaEFYI2rOFTtCC6w4rhVQOEYnOd9gjBuF4Rk6JlJiIYEuEF9dfyOVD-1oXa6s6_uqdWbYVsM2xXGzLSFjB39vBh9DFbtq9fX6kj5HTzvTZ_div56iH5cX31ef6qsvHz-vzq9qKzAeauFI61ohuOXrhijVAnSGEdsy1ijLgJiuI0pwYJYzLssLXWPBlLHUSoU7eoo-zHlvx_XOtdaFIZle3ya_M-mnjsbrx5Hgt3oT7zUoIqGBkuDtPkGKd6PLg975PN3SBBfHrIWQpSgM_xcChkZIJgt8_Qe8iWMKpQoaoKGCEMoLejOjjemd9qGL5XR2yqjPiQLgSglV1PIvqjyt23lbutz58v3RhnfzBptizsl1D5UgWE_DoMsw6GkYdBmGwl_9Xr0D3ne_gLM9MNmavksmWJ8fHBCgTBJWXD27XEJh49Lhzv_4cTX7YIYxuUO_gp3MRH4BobvUvQ
CODEN ONCNES
CitedBy_id crossref_primary_10_1002_wrna_59
crossref_primary_10_3390_cells4020178
crossref_primary_10_1038_onc_2011_29
crossref_primary_10_1016_j_ajpath_2024_02_017
crossref_primary_10_3892_ol_2019_10659
crossref_primary_10_1016_j_isci_2022_104804
crossref_primary_10_1038_s41467_022_28330_8
crossref_primary_10_1016_j_ajpath_2013_05_010
crossref_primary_10_3389_fgene_2022_854907
crossref_primary_10_1158_1541_7786_MCR_15_0489
crossref_primary_10_1186_s12885_022_10103_7
crossref_primary_10_1074_jbc_M114_622761
crossref_primary_10_1002_hep4_1724
crossref_primary_10_1071_RD18411
crossref_primary_10_1186_s40364_020_00249_6
crossref_primary_10_1016_j_ajpath_2012_04_016
crossref_primary_10_1016_j_gene_2023_148013
crossref_primary_10_1093_nar_gkp1176
crossref_primary_10_1186_s13046_019_1263_3
crossref_primary_10_2217_bmm_2021_0039
crossref_primary_10_1016_j_ajpath_2012_11_020
crossref_primary_10_1002_mc_22494
crossref_primary_10_3390_cancers15164057
crossref_primary_10_7717_peerj_16616
crossref_primary_10_1002_gcc_22211
crossref_primary_10_1016_j_jid_2020_10_027
crossref_primary_10_1016_j_humpath_2011_06_003
crossref_primary_10_1016_j_ajpath_2015_03_015
crossref_primary_10_1038_s41421_024_00654_3
crossref_primary_10_1080_21505594_2018_1475795
crossref_primary_10_1016_j_cell_2013_11_027
crossref_primary_10_1038_nbt_3843
crossref_primary_10_3906_biy_1505_94
crossref_primary_10_1097_HC9_0000000000000412
crossref_primary_10_1016_j_tibs_2021_04_003
crossref_primary_10_1074_jbc_M109_061705
Cites_doi 10.1002/mc.10018
10.3322/CA.2007.0010
10.1177/41.1.7678025
10.1016/j.canlet.2005.05.033
10.1200/JCO.2004.05.158
10.1261/rna.5214404
10.1016/j.cell.2005.08.002
10.3322/canjclin.55.1.10
10.1128/MCB.25.4.1489-1500.2005
10.1093/hmg/7.6.1039
10.1002/ijc.20254
10.3322/canjclin.57.1.43
10.1158/0008-5472.CAN-06-0227
10.1002/gcc.2870070204
10.2353/ajpath.2006.050620
ContentType Journal Article
Copyright Macmillan Publishers Limited 2009
2009 INIST-CNRS
COPYRIGHT 2009 Nature Publishing Group
Copyright Nature Publishing Group Jan 8, 2009
2009 Macmillan Publishers Limited All rights reserved 2009
Copyright_xml – notice: Macmillan Publishers Limited 2009
– notice: 2009 INIST-CNRS
– notice: COPYRIGHT 2009 Nature Publishing Group
– notice: Copyright Nature Publishing Group Jan 8, 2009
– notice: 2009 Macmillan Publishers Limited All rights reserved 2009
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TM
7TO
7U9
7X7
7XB
88A
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
P64
PQEST
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
5PM
DOI 10.1038/onc.2008.359
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Research Library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic


Research Library Prep


AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
EISSN 1476-5594
EndPage 51
ExternalDocumentID 1623260571
A192259969
10_1038_onc_2008_359
18806823
21234814
onc2008359
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA098249-03
– fundername: NCI NIH HHS
  grantid: R01 CA098249-02
– fundername: NCATS NIH HHS
  grantid: UL1 TR000005
– fundername: NCI NIH HHS
  grantid: R01 CA098249
– fundername: NCI NIH HHS
  grantid: R01 CA098249-05
– fundername: NCI NIH HHS
  grantid: R01 CA098249-04
– fundername: NCI NIH HHS
  grantid: R01 CA098249-01A1
GroupedDBID -
-Q-
0R
123
29N
2WC
39C
3O-
3V.
4.4
53G
5RE
70F
7X7
88A
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AADWK
AAPBV
AAWBL
AAYJO
AAZLF
ABAWZ
ABDBF
ABDEU
ABFLS
ABGIJ
ABPTK
ABUWG
ACGFS
ACKTT
ACPRK
ADBBV
ADHDB
ADQMX
AEDAW
AEJRE
AENEX
AEXYK
AFKRA
AFSHS
AGEZK
AHMBA
AHSBF
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B0M
BBAFP
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
COF
CS3
DIK
DU5
DWQXO
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EPL
ESX
F5P
FDQFY
FEDTE
FERAY
FIZPM
FRP
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HVGLF
HZ
IAO
IHR
INH
INR
ITC
JSO
KQ8
L7B
LK8
M0L
M1P
M2O
M7P
N9A
NAO
O9-
OK1
OVD
P2P
PADUT
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q-
Q2X
RIG
RNS
RNT
RNTTT
SNX
SNYQT
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TSG
TUS
W2D
WH7
ZA5
---
0R~
36B
406
AANZL
ABAKF
ABJNI
ABLJU
ABZZP
ACAOD
ACGFO
ACMJI
ACRQY
ACZOJ
ADFRT
AEMSY
AEVLU
AFBBN
AGHAI
AGQEE
AILAN
ALIPV
AMYLF
CCPQU
DNIVK
DPUIP
EMOBN
HMCUK
HZ~
IWAJR
JZLTJ
NQJWS
NXXTH
SOHCF
SRMVM
UKHRP
~8M
.55
.GJ
08R
AATNV
AAUGY
AAYFA
ABEFU
ACBMV
ACBRV
ACBYP
ACIGE
ACTTH
ACVWB
ADMDM
ADYYL
AEFTE
AFFNX
AFNRJ
AGGBP
AJCLW
AJDOV
AMRJV
BAWUL
IQODW
NYICJ
TR2
UDS
X7M
ZXP
AAYZH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
FIGPU
7TM
7TO
7U9
7XB
8FD
8FK
FR3
H94
K9.
MBDVC
P64
Q9U
RC3
7X8
5PM
ID FETCH-LOGICAL-c600t-6e1ded665c5b7199d22fa41cd4479c421aff196524c5458ff13b0649ac3c890f3
IEDL.DBID BENPR
ISSN 0950-9232
IngestDate Tue Sep 17 21:22:22 EDT 2024
Fri Oct 25 03:58:38 EDT 2024
Fri Oct 25 02:33:18 EDT 2024
Thu Oct 10 20:05:32 EDT 2024
Fri Feb 23 00:21:35 EST 2024
Tue Feb 06 05:23:05 EST 2024
Fri Sep 27 02:37:10 EDT 2024
Tue Oct 15 23:40:50 EDT 2024
Sun Oct 22 16:09:51 EDT 2023
Fri Oct 11 20:47:27 EDT 2024
Thu Oct 07 19:37:30 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords CSR1
RNA polyadenylation
cell death
CPSF3
RNA
Cell death
Polyadenylation
Inactivation
Carcinogenesis
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c600t-6e1ded665c5b7199d22fa41cd4479c421aff196524c5458ff13b0649ac3c890f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1038/onc.2008.359
PMID 18806823
PQID 227361135
PQPubID 36330
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2918272
proquest_miscellaneous_66800740
proquest_miscellaneous_20276848
proquest_journals_227361135
gale_infotracmisc_A192259969
gale_infotracacademiconefile_A192259969
crossref_primary_10_1038_onc_2008_359
pubmed_primary_18806823
pascalfrancis_primary_21234814
springer_journals_10_1038_onc_2008_359
nature_primary_onc2008359
ProviderPackageCode ABDEU
AEDAW
AAZLF
-Q-
AADWK
AAYJO
70F
ADQMX
EE.
RNTTT
SWTZT
ABGIJ
RNT
NAO
PublicationCentury 2000
PublicationDate 2009-01-08
PublicationDateYYYYMMDD 2009-01-08
PublicationDate_xml – month: 01
  year: 2009
  text: 2009-01-08
  day: 08
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: Basingstoke
– name: England
– name: New York
PublicationTitle Oncogene
PublicationTitleAbbrev Oncogene
PublicationTitleAlternate Oncogene
PublicationYear 2009
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Dominski, Z, Yang, XC, Marzluff, WF 2005a; 123
Jemal, A, Siegel, R, Ward, E, Murray, T, Xu, J, Thun, MJ 2007; 57
Coon, SW, Savera, AT, Zarbo, RJ, Benninger, MS, Chase, GA, Rybicki, BA 2004; 111
Han, HJ, Tokino, T, Nakamura, Y 1998; 7
Yu, YP, Luo, JH 2006; 66
Wijsman, JH, Jonker, RR, Keijzer, R, van de Velde, CJ, Cornelisse, CJ, van Dierendonck, JH 1993; 41
Kurimoto, F, Gemma, A, Hosoya, Y, Seike, M, Takenaka, K, Uematsu, K 2001; 8
Yu, YP, Landsittel, D, Jing, L, Nelson, J, Ren, B, Liu, L 2004; 22
Luo, JH, Yu, YP, Cieply, K, Lin, F, Deflavia, P, Dhir, R 2002; 33
Ryan, K, Calvo, O, Manley, JL 2004; 10
Jemal, A, Siegel, R, Ward, E, Hao, Y, Xu, J, Murray, T 2008; 58
Wistuba, II, Behrens, C, Virmani, AK, Milchgrub, S, Syed, S, Lam, S 1999; 59
Yu, G, Tseng, GC, Yu, YP, Gavel, T, Nelson, J, Wells, A 2006; 168
Isaacs, JT 1997; 150
Gallucci, M, Merola, R, Farsetti, A, Orlandi, G, Sentinelli, S, De Carli, P 2006; 237
Jemal, A, Murray, T, Ward, E, Samuels, A, Tiwari, RC, Ghafoor, A 2005; 55
Ohata, H, Emi, M, Fujiwara, Y, Higashino, K, Nakagawa, K, Futagami, R 1993; 7
Dominski, Z, Yang, XC, Purdy, M, Wagner, EJ, Marzluff, WF 2005b; 25
Gallucci, Merola, Farsetti, Orlandi, Sentinelli, De Carli (CR4) 2006; 237
Ryan, Calvo, Manley (CR13) 2004; 10
Jemal, Siegel, Ward, Hao, Xu, Murray (CR8) 2008; 58
Wijsman, Jonker, Keijzer, van de Velde, Cornelisse, van Dierendonck (CR14) 1993; 41
Wistuba, Behrens, Virmani, Milchgrub, Syed, Lam (CR15) 1999; 59
Yu, Tseng, Yu, Gavel, Nelson, Wells (CR16) 2006; 168
Isaacs (CR6) 1997; 150
Han, Tokino, Nakamura (CR5) 1998; 7
Dominski, Yang, Marzluff (CR2) 2005; 123
Coon, Savera, Zarbo, Benninger, Chase, Rybicki (CR1) 2004; 111
Jemal, Murray, Ward, Samuels, Tiwari, Ghafoor (CR7) 2005; 55
Jemal, Siegel, Ward, Murray, Xu, Thun (CR9) 2007; 57
Ohata, Emi, Fujiwara, Higashino, Nakagawa, Futagami (CR12) 1993; 7
Yu, Landsittel, Jing, Nelson, Ren, Liu (CR17) 2004; 22
Kurimoto, Gemma, Hosoya, Seike, Takenaka, Uematsu (CR10) 2001; 8
Yu, Luo (CR18) 2006; 66
Luo, Yu, Cieply, Lin, Deflavia, Dhir (CR11) 2002; 33
Dominski, Yang, Purdy, Wagner, Marzluff (CR3) 2005; 25
9137077 - Am J Pathol. 1997 May;150(5):1511-21
15661684 - CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30
15684398 - Mol Cell Biol. 2005 Feb;25(4):1489-500
9580669 - Hum Mol Genet. 1998 Jun;7(6):1039-46
15037765 - RNA. 2004 Apr;10(4):565-73
11807955 - Mol Carcinog. 2002 Jan;33(1):25-35
16213211 - Cell. 2005 Oct 7;123(1):37-48
16436673 - Am J Pathol. 2006 Feb;168(2):597-607
7687457 - Genes Chromosomes Cancer. 1993 Jun;7(2):85-8
16885336 - Cancer Res. 2006 Aug 1;66(15):7414-9
15254046 - J Clin Oncol. 2004 Jul 15;22(14):2790-9
11408955 - Int J Mol Med. 2001 Jul;8(1):89-93
15197772 - Int J Cancer. 2004 Aug 20;111(2):206-12
16002207 - Cancer Lett. 2006 Jun 8;237(1):76-82
17237035 - CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
18287387 - CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
7678025 - J Histochem Cytochem. 1993 Jan;41(1):7-12
10213509 - Cancer Res. 1999 Apr 15;59(8):1973-9
SW Coon (BFonc2008359_CR1) 2004; 111
A Jemal (BFonc2008359_CR9) 2007; 57
Z Dominski (BFonc2008359_CR3) 2005; 25
K Ryan (BFonc2008359_CR13) 2004; 10
Z Dominski (BFonc2008359_CR2) 2005; 123
M Gallucci (BFonc2008359_CR4) 2006; 237
II Wistuba (BFonc2008359_CR15) 1999; 59
G Yu (BFonc2008359_CR16) 2006; 168
JH Wijsman (BFonc2008359_CR14) 1993; 41
YP Yu (BFonc2008359_CR17) 2004; 22
H Ohata (BFonc2008359_CR12) 1993; 7
YP Yu (BFonc2008359_CR18) 2006; 66
JH Luo (BFonc2008359_CR11) 2002; 33
A Jemal (BFonc2008359_CR8) 2008; 58
JT Isaacs (BFonc2008359_CR6) 1997; 150
HJ Han (BFonc2008359_CR5) 1998; 7
F Kurimoto (BFonc2008359_CR10) 2001; 8
A Jemal (BFonc2008359_CR7) 2005; 55
References_xml – volume: 25
  start-page: 1489
  year: 2005b
  end-page: 1500
  article-title: A cpsf-73 homologue is required for cell cycle progression but not cell growth and interacts with a protein having features of cpsf-100
  publication-title: Mol Cell Biol
  contributor:
    fullname: Marzluff, WF
– volume: 168
  start-page: 597
  year: 2006
  end-page: 607
  article-title: Csr1 suppresses tumor growth and metastasis of prostate cancer
  publication-title: Am J Pathol
  contributor:
    fullname: Wells, A
– volume: 58
  start-page: 71
  year: 2008
  end-page: 96
  article-title: Cancer statistics, 2008
  publication-title: CA Cancer J Clin
  contributor:
    fullname: Murray, T
– volume: 41
  start-page: 7
  year: 1993
  end-page: 12
  article-title: A new method to detect apoptosis in paraffin sections: end-labeling of fragmented DNA
  publication-title: J Histochem Cytochem
  contributor:
    fullname: van Dierendonck, JH
– volume: 33
  start-page: 25
  year: 2002
  end-page: 35
  article-title: Gene expression analysis of prostate cancers
  publication-title: Mol Carcinog
  contributor:
    fullname: Dhir, R
– volume: 237
  start-page: 76
  year: 2006
  end-page: 82
  article-title: Cytogenetic profiles as additional markers to pathological features in clinically localized prostate carcinoma
  publication-title: Cancer Lett
  contributor:
    fullname: De Carli, P
– volume: 66
  start-page: 7414
  year: 2006
  end-page: 7419
  article-title: Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin
  publication-title: Cancer Research
  contributor:
    fullname: Luo, JH
– volume: 55
  start-page: 10
  year: 2005
  end-page: 30
  article-title: Cancer statistics, 2005
  publication-title: CA Cancer J Clin
  contributor:
    fullname: Ghafoor, A
– volume: 59
  start-page: 1973
  year: 1999
  end-page: 1979.
  article-title: Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer
  publication-title: Cancer Res
  contributor:
    fullname: Lam, S
– volume: 123
  start-page: 37
  year: 2005a
  end-page: 48
  article-title: The polyadenylation factor cpsf-73 is involved in histone-pre-mrna processing
  publication-title: Cell
  contributor:
    fullname: Marzluff, WF
– volume: 7
  start-page: 1039
  year: 1998
  end-page: 1046
  article-title: Csr, a scavenger receptor-like protein with a protective role against cellular damage caused by UV irradiation and oxidative stress
  publication-title: Hum Mol Genet
  contributor:
    fullname: Nakamura, Y
– volume: 57
  start-page: 43
  year: 2007
  end-page: 66
  article-title: Cancer statistics, 2007
  publication-title: CA Cancer J Clin
  contributor:
    fullname: Thun, MJ
– volume: 111
  start-page: 206
  year: 2004
  end-page: 212
  article-title: Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma
  publication-title: Int J Cancer
  contributor:
    fullname: Rybicki, BA
– volume: 150
  start-page: 1511
  year: 1997
  end-page: 1521
  article-title: Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer
  publication-title: Am J Pathol
  contributor:
    fullname: Isaacs, JT
– volume: 10
  start-page: 565
  year: 2004
  end-page: 573
  article-title: Evidence that polyadenylation factor cpsf-73 is the mrna 3′ processing endonuclease
  publication-title: RNA
  contributor:
    fullname: Manley, JL
– volume: 8
  start-page: 89
  year: 2001
  end-page: 93
  article-title: Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21-23 during metastasis of lung cancer
  publication-title: Int J Mol Med
  contributor:
    fullname: Uematsu, K
– volume: 7
  start-page: 85
  year: 1993
  end-page: 88
  article-title: Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma
  publication-title: Genes Chromosomes Cancer
  contributor:
    fullname: Futagami, R
– volume: 22
  start-page: 2790
  year: 2004
  end-page: 2799
  article-title: Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
  publication-title: J Clin Oncol
  contributor:
    fullname: Liu, L
– volume: 33
  start-page: 25
  year: 2002
  end-page: 35
  ident: CR11
  article-title: Gene expression analysis of prostate cancers
  publication-title: Mol Carcinog
  doi: 10.1002/mc.10018
  contributor:
    fullname: Dhir
– volume: 8
  start-page: 89
  year: 2001
  end-page: 93
  ident: CR10
  article-title: Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21–23 during metastasis of lung cancer
  publication-title: Int J Mol Med
  contributor:
    fullname: Uematsu
– volume: 58
  start-page: 71
  year: 2008
  end-page: 96
  ident: CR8
  article-title: Cancer statistics, 2008
  publication-title: CA Cancer J Clin
  doi: 10.3322/CA.2007.0010
  contributor:
    fullname: Murray
– volume: 41
  start-page: 7
  year: 1993
  end-page: 12
  ident: CR14
  article-title: A new method to detect apoptosis in paraffin sections: end-labeling of fragmented DNA
  publication-title: J Histochem Cytochem
  doi: 10.1177/41.1.7678025
  contributor:
    fullname: van Dierendonck
– volume: 237
  start-page: 76
  year: 2006
  end-page: 82
  ident: CR4
  article-title: Cytogenetic profiles as additional markers to pathological features in clinically localized prostate carcinoma
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2005.05.033
  contributor:
    fullname: De Carli
– volume: 22
  start-page: 2790
  year: 2004
  end-page: 2799
  ident: CR17
  article-title: Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.05.158
  contributor:
    fullname: Liu
– volume: 10
  start-page: 565
  year: 2004
  end-page: 573
  ident: CR13
  article-title: Evidence that polyadenylation factor cpsf-73 is the mrna 3′ processing endonuclease
  publication-title: RNA
  doi: 10.1261/rna.5214404
  contributor:
    fullname: Manley
– volume: 123
  start-page: 37
  year: 2005
  end-page: 48
  ident: CR2
  article-title: The polyadenylation factor cpsf-73 is involved in histone-pre-mrna processing
  publication-title: Cell
  doi: 10.1016/j.cell.2005.08.002
  contributor:
    fullname: Marzluff
– volume: 55
  start-page: 10
  year: 2005
  end-page: 30
  ident: CR7
  article-title: Cancer statistics, 2005
  publication-title: CA Cancer J Clin
  doi: 10.3322/canjclin.55.1.10
  contributor:
    fullname: Ghafoor
– volume: 25
  start-page: 1489
  year: 2005
  end-page: 1500
  ident: CR3
  article-title: A cpsf-73 homologue is required for cell cycle progression but not cell growth and interacts with a protein having features of cpsf-100
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.25.4.1489-1500.2005
  contributor:
    fullname: Marzluff
– volume: 7
  start-page: 1039
  year: 1998
  end-page: 1046
  ident: CR5
  article-title: Csr, a scavenger receptor-like protein with a protective role against cellular damage caused by UV irradiation and oxidative stress
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/7.6.1039
  contributor:
    fullname: Nakamura
– volume: 150
  start-page: 1511
  year: 1997
  end-page: 1521
  ident: CR6
  article-title: Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer
  publication-title: Am J Pathol
  contributor:
    fullname: Isaacs
– volume: 111
  start-page: 206
  year: 2004
  end-page: 212
  ident: CR1
  article-title: Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma
  publication-title: Int J Cancer
  doi: 10.1002/ijc.20254
  contributor:
    fullname: Rybicki
– volume: 57
  start-page: 43
  year: 2007
  end-page: 66
  ident: CR9
  article-title: Cancer statistics, 2007
  publication-title: CA Cancer J Clin
  doi: 10.3322/canjclin.57.1.43
  contributor:
    fullname: Thun
– volume: 66
  start-page: 7414
  year: 2006
  end-page: 7419
  ident: CR18
  article-title: Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin
  publication-title: Cancer Research
  doi: 10.1158/0008-5472.CAN-06-0227
  contributor:
    fullname: Luo
– volume: 7
  start-page: 85
  year: 1993
  end-page: 88
  ident: CR12
  article-title: Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.2870070204
  contributor:
    fullname: Futagami
– volume: 59
  start-page: 1973
  year: 1999
  end-page: 1979.
  ident: CR15
  article-title: Allelic losses at chromosome 8p21–23 are early and frequent events in the pathogenesis of lung cancer
  publication-title: Cancer Res
  contributor:
    fullname: Lam
– volume: 168
  start-page: 597
  year: 2006
  end-page: 607
  ident: CR16
  article-title: Csr1 suppresses tumor growth and metastasis of prostate cancer
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.050620
  contributor:
    fullname: Wells
– volume: 22
  start-page: 2790
  year: 2004
  ident: BFonc2008359_CR17
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.05.158
  contributor:
    fullname: YP Yu
– volume: 123
  start-page: 37
  year: 2005
  ident: BFonc2008359_CR2
  publication-title: Cell
  doi: 10.1016/j.cell.2005.08.002
  contributor:
    fullname: Z Dominski
– volume: 33
  start-page: 25
  year: 2002
  ident: BFonc2008359_CR11
  publication-title: Mol Carcinog
  doi: 10.1002/mc.10018
  contributor:
    fullname: JH Luo
– volume: 7
  start-page: 85
  year: 1993
  ident: BFonc2008359_CR12
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.2870070204
  contributor:
    fullname: H Ohata
– volume: 66
  start-page: 7414
  year: 2006
  ident: BFonc2008359_CR18
  publication-title: Cancer Research
  doi: 10.1158/0008-5472.CAN-06-0227
  contributor:
    fullname: YP Yu
– volume: 8
  start-page: 89
  year: 2001
  ident: BFonc2008359_CR10
  publication-title: Int J Mol Med
  contributor:
    fullname: F Kurimoto
– volume: 55
  start-page: 10
  year: 2005
  ident: BFonc2008359_CR7
  publication-title: CA Cancer J Clin
  doi: 10.3322/canjclin.55.1.10
  contributor:
    fullname: A Jemal
– volume: 7
  start-page: 1039
  year: 1998
  ident: BFonc2008359_CR5
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/7.6.1039
  contributor:
    fullname: HJ Han
– volume: 150
  start-page: 1511
  year: 1997
  ident: BFonc2008359_CR6
  publication-title: Am J Pathol
  contributor:
    fullname: JT Isaacs
– volume: 25
  start-page: 1489
  year: 2005
  ident: BFonc2008359_CR3
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.25.4.1489-1500.2005
  contributor:
    fullname: Z Dominski
– volume: 237
  start-page: 76
  year: 2006
  ident: BFonc2008359_CR4
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2005.05.033
  contributor:
    fullname: M Gallucci
– volume: 168
  start-page: 597
  year: 2006
  ident: BFonc2008359_CR16
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.050620
  contributor:
    fullname: G Yu
– volume: 58
  start-page: 71
  year: 2008
  ident: BFonc2008359_CR8
  publication-title: CA Cancer J Clin
  doi: 10.3322/CA.2007.0010
  contributor:
    fullname: A Jemal
– volume: 41
  start-page: 7
  year: 1993
  ident: BFonc2008359_CR14
  publication-title: J Histochem Cytochem
  doi: 10.1177/41.1.7678025
  contributor:
    fullname: JH Wijsman
– volume: 59
  start-page: 1973
  year: 1999
  ident: BFonc2008359_CR15
  publication-title: Cancer Res
  contributor:
    fullname: II Wistuba
– volume: 111
  start-page: 206
  year: 2004
  ident: BFonc2008359_CR1
  publication-title: Int J Cancer
  doi: 10.1002/ijc.20254
  contributor:
    fullname: SW Coon
– volume: 10
  start-page: 565
  year: 2004
  ident: BFonc2008359_CR13
  publication-title: RNA
  doi: 10.1261/rna.5214404
  contributor:
    fullname: K Ryan
– volume: 57
  start-page: 43
  year: 2007
  ident: BFonc2008359_CR9
  publication-title: CA Cancer J Clin
  doi: 10.3322/canjclin.57.1.43
  contributor:
    fullname: A Jemal
SSID ssj0007902
Score 2.1770542
Snippet CSR1 (cellular stress response 1), a newly characterized tumor-suppressor gene, undergoes hypermethylation in over 30% of prostate cancers. Re-expression of...
CSR1 (cellular stress response 1), a newly characterized tumor-suppressor gene, undergoes hypermethylation in over 30% of prostate cancers. Re- expression of...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
pascalfrancis
springer
nature
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 41
SubjectTerms Ageing, cell death
Apoptosis
Biological and medical sciences
Cancer
Care and treatment
Causes of
Cell Biology
Cell death
Cell Line
Cell Nucleus - metabolism
Cell physiology
Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes
Cleavage And Polyadenylation Specificity Factor - antagonists & inhibitors
Cleavage And Polyadenylation Specificity Factor - genetics
Cleavage And Polyadenylation Specificity Factor - metabolism
Cytoplasm - metabolism
Fundamental and applied biological sciences. Psychology
Gene expression
Gene Library
Genetic aspects
Heat-Shock Proteins - genetics
Heat-Shock Proteins - metabolism
Human Genetics
Humans
Internal Medicine
Male
Medicine
Medicine & Public Health
Molecular and cellular biology
Oncology
original-article
Physiological aspects
Polyadenylation
Prostate - metabolism
Prostate cancer
Protein Transport
Ribozymes
RNA
RNA, Small Interfering - genetics
Scavenger Receptors, Class A - genetics
Scavenger Receptors, Class A - metabolism
Tumor suppressor genes
Two-Hybrid System Techniques
Title CSR1 induces cell death through inactivation of CPSF3
URI http://dx.doi.org/10.1038/onc.2008.359
https://link.springer.com/article/10.1038/onc.2008.359
https://www.ncbi.nlm.nih.gov/pubmed/18806823
https://www.proquest.com/docview/227361135
https://search.proquest.com/docview/20276848
https://search.proquest.com/docview/66800740
https://pubmed.ncbi.nlm.nih.gov/PMC2918272
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7RrXhICMECJbQsOfA4RY0f8eOEStRVhdSqaqm0t8hxErWX7NLdHvj3jGMnS6BwiRTNSE7G4_E3nvEMwIdGp8LUVieyykTCWcMSbbROqGhYictJqa6dz-mZOLni3xbZIuTmrENaZW8TO0NdLa07Iz-kuM8KQlj2ZfUjcU2jXHA1dNDYgV2KjkI6gd2vx2fnF4Mplj7pEGFEmiCSoSHzPWXqcNlan0nJXJnS3_akYJmHwppPV2aN4mp8n4v7gOjf-ZR_BFW7vWr-HJ4FkBkfea14AQ_qdgoPfdvJn1N4nPdd3qbw6DQE119Cll9ekBh9dJztdexO9OPKAcQ49PJBkrsF4c9w42UT5-eXc_YKrubH3_OTJHRVSCyCm00ialLVlRCZzUpJtK4obQwntuJcasspMU3jygxSbl1QDV9YibhFG8us0mnDXsOkXbb1G4g1F0yWtillJbkxvGSGlFJUAp1GUfEsgo-9XIuVL55RdEFvpgqUv2-BifKP4LMTeuHWFArQmnA1AEdx1amKI4Sh1NWRQc6DEScKy47IkZ-2YTgchnYwE2mz0UwOLG7z5orwCPb7qS3CQl4Xg9pF8H6gulFdblpbL--QBT17obj6N4cQykG1NII9ryhbaaD5FIqyCORIhbbfb26KMaW9ue6qgFONrqGkEXzqlW371fcJ-e1_f28fnvg4mTswP4DJ5vaufodwa1POYEcuJD5VTmZhgf0CZM4oVA
link.rule.ids 230,315,783,787,888,12068,12235,21400,27936,27937,31731,31732,33278,33279,33756,33757,43322,43591,43817,74079,74348,74636
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BERQJIVighJY2Bx6nqInt-HFC1YrVAt0K0VbaW-Q4seglWbrbA_-ecexkCRSO0YzkZDy2v_FM5gN4Y1XKdW1UIqqcJ4xamiitVEK4pSUuJyk7Op_FGZ9fss_LfBlqc9ahrLLfE7uNumqNuyM_JnjO8iyj-YfVj8SRRrnkamDQuAv3XBsuR2AglkO8lQpfcoggIk0Qx5BQ955Sedw2xtdRUtek9LcTKezLQ1vNRyu9RmNZz3JxGwz9u5ryj5Rqd1LNnsDjADHjE-8TT-FO3Uzgvied_DmB3WnP8TaBB4uQWn8G-fT8WxZjhI5zvY7dfX5cOXgYByYfFLl_IPwNbtzaePr1fEafw-Xs48V0ngROhcQgtNkkvM6quuI8N3kpMqUqQqxmmakYE8owkmlrXZNBwoxLqeEDLRG1KG2okSq19AXsNG1Tv4RYMU5FaWwpKsG0ZiXVWSl4xTFk5BXLI3jb27VY-dYZRZfyprJA-3sCTLR_BO-d0Qu3otCARocfA3AU15uqOEEQSlwXGdQ8GGmiscxIHPlpG4bDYUgHMlF2OJrJQcUd3UxmLIL9fmqLsIzXxeB0ERwNUjeqq0xr6vYGVTCu55LJf2twLh1QSyPY846ytQZunlwSGoEYudD2_fVVMZY0V9-7HuBEYWAoSATvemfbvvVtRn713887gt35xeK0OP109mUfHvqMmbs6P4CdzfVN_RqB16Y87JbXL56vKCs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BEQUJIVheoaXNgccp2sR2_DihamFVHq0qSqW9RY4di16Shd0e-PeMYyfLQuGYzEhOxjP2N57xDMBLp3KuG6MyYUueMepoprRSGeGO1mhOUvbtfE5O-fEF-7goF7Gk0CqmVQ5rYr9Q2874M_IpwX2WFwUtpy5mRZy9m79dfs98AykfaI3dNG7CLYFOildwsRh9L3zRpx8ioMgzxDQk5sDnVE671oScSuoLlv62O8U1eiyxeW-pVyg4FzpeXAdJ_86s_CO82u9a8wdwP8LN9Cjox0O40bQTuB0aUP6cwJ3Z0O9tArsnMcz-CMrZ-ZciRW8d532V-rP91HqomMauPkjy9yHCaW7auXR2dj6nj-Fi_v7r7DiL_RUygzBnnfGmsI3lvDRlLQqlLCFOs8JYxoQyjBTaOV9wkDDjw2v4QGtEMEobaqTKHX0CO23XNs8gVYxTURtXCyuY1qymuqgFtxzdR25ZmcCrQa7VMpTRqPrwN5UVyj80w0T5J_DGC73y1oUCNDpeEsBRfJ2q6ggBKfEVZZBzf4sThWW2yEmYtnE4HIb0gBNpB1szObL4bZzJgiWwN0xtFU16VY0KmMDhSPWj-iy1tumukAV9fC6Z_DcH59KDtjyBp0FRNtLAhZRLQhMQWyq0-X59WW1T2stvfT1wotBJFCSB14Oybb76OiE__-_vHcIuWlb1-cPppz24G4Jn_hR9H3bWP66aF4jB1vVBb12_AO5MLGk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CSR1+induces+cell+death+through+inactivation+of+CPSF3&rft.jtitle=Oncogene&rft.au=Zhu%2C+Z.-H&rft.au=Yu%2C+Y.P&rft.au=Shi%2C+Y.-K&rft.au=Nelson%2C+J.B&rft.date=2009-01-08&rft.pub=Nature+Publishing+Group&rft.issn=0950-9232&rft.eissn=1476-5594&rft.volume=28&rft.issue=1&rft.spage=41&rft_id=info:doi/10.1038%2Fonc.2008.359&rft.externalDocID=A192259969
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon